Webinar

Technology Integrators In Cell And Gene Therapy: Powering Innovation

Source: Catalent

The cell and gene therapy markets are seeing growth in the use of allogeneic and autologous cell therapies as well as viral vectors for gene therapy and ex-vivo transduction of the cell therapies. Both require investments in technologies to enhance safety and efficacy as well as reduce production costs. Accelerated clinical trial timelines for advanced therapeutics are on the rise.  With fast track status designations, it is increasingly critical for innovators to have efficient and scalable production processes. Early partnerships with a contract manufacturer can help assure optimized manufacturing processes to reduce industrialization challenges and achieve commercial-readiness.

Julien Meissonnier, Catalent’s Vice President and Chief Scientific Officer, discusses innovative approaches, technology disrupters, and more in this webinar.

VIEW THE WEBINAR!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Outsourced Pharma? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: